AI IS WHERE THE DATA IS
Live / Registered — Registered (as of 05 Apr 2022)
What this means for you
Registered since 05 Apr 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90812123
- Registration number
- 6693951
- Mark type
- Stylized text
- Filed
- 06 Jul 2021
- Published for opposition
- 18 Jan 2022
- Registered
- 05 Apr 2022
- Attorney of record
- Anna Kurian Shaw
Goods and services
- Class 009 — Scientific and electric apparatus: Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer software
- Class 035 — Advertising and business services: Statistical services and modeling with respect to cancer treatment and cancer diagnosis
- Class 042 — Scientific and technological services: Computer programming in the medical, pharmaceutical and biotechnological field; database design; database maintenance; programming of software for importing and managing data; information technology services for the pharmaceutical and healthcare industries; Computer programming for data processing; non-downloadable computer software; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology
- Class 044 — Medical, beauty and agricultural services: Medical and pharmaceutical services
Owner
- Immatics Biotechnologies GmbH, Tübingen, DE
- Immatics Biotechnologies GmbH, Tuebingen, DE
- Immatics Biotechnologies GmbH, Tuebingen, DE
Prosecution history
- 02 Nov 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Nov 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Nov 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Nov 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Apr 2022 — REGISTERED-PRINCIPAL REGISTER
- 18 Jan 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jan 2022 — PUBLISHED FOR OPPOSITION
- 29 Dec 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Dec 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Dec 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Dec 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Dec 2021 — ASSIGNED TO LIE
- 06 Dec 2021 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 21 Sept 2021 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED